Latest imported 13F data
RARE

ULTRAGENYX PHARMACEUTICAL IN

Institutional Ownership · Q4 2025

Filing: Q4 2025

ULTRAGENYX PHARMACEUTICAL IN (RARE) is held by 277 institutional investors with combined holdings of $4.3B. Major holders include Stonepine Capital Managem, VANGUARD GROUP INC, BlackRock, Inc..

💰 Dark Pool Activity👤 Insider Trades
Institutional Holders
277
Total Value
$4.3B
Ownership %
86.9%

🏦 Top Institutional Holders

Stonepine Capital Management, LLC
100.0K shares
$2.3B
0.10% ownership
VANGUARD GROUP INC
10.3M shares
$236.1M
10.42% ownership
BlackRock, Inc.
6.6M shares
$152.5M
6.73% ownership
STATE STREET CORP
4.3M shares
$99.0M
4.37% ownership
JPMORGAN CHASE & CO
4.0M shares
$91.4M
4.03% ownership

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.